Article: Elidel cream 1% shown effective treatment with proven safety profile for infant eczema, study reports.

Basel, Switzerland -- Basel, Switzerland, February 24 /PRNewswire/ -- - Journal of Pediatrics cites Elidel as 'promising' new option for infants

A new publication suggests that Elidel(R) (pimecrolimus) cream 1% is an effective treatment with a proven safety profile for eczema (atopic dermatitis) in infants as young as 3 months, according to a report in the February issue of the Journal of Pediatrics (February 2003, 142(2):155-162). The study found that after six weeks, more than twice as many patients treated with Elidel were clear or almost clear of eczema, compared with those treated with the vehicle (Elidel cream base without the active ingredient). In the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!